Your browser doesn't support javascript.
loading
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.
Cass, S H; Tobin, J W D; Seo, Y D; Gener-Ricos, G; Keung, E Z; Burton, E M; Davies, M A; McQuade, J L; Lazar, A J; Mason, R; Millward, M; Sandhu, S; Khoo, C; Warburton, L; Guerra, V; Haydon, A; Dearden, H; Menzies, A M; Carlino, M S; Smith, J L; Mollee, P; Burgess, M; Mapp, S; Keane, C; Atkinson, V; Parikh, S A; Markovic, S N; Ding, W; Call, T G; Hampel, P J; Long, G V; Wargo, J A; Ferrajoli, A.
Afiliação
  • Cass SH; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Tobin JWD; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.
  • Seo YD; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gener-Ricos G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.
  • Keung EZ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Burton EM; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • McQuade JL; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Lazar AJ; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Mason R; Gold Coast University Hospital, Southport.
  • Millward M; University of Western Australia, Perth.
  • Sandhu S; Peter Macallum Cancer Centre, Melbourne.
  • Khoo C; Peter Macallum Cancer Centre, Melbourne.
  • Warburton L; Fiona Stanley Hospital, Perth; Edith Cowan University, Joondalup; Future Health Research and Innovation Fund/Raine Clinician Research Fellowship.
  • Guerra V; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.
  • Haydon A; Alfred Hospital, Melbourne.
  • Dearden H; Melanoma Institute Australia, The University of Sydney, Sydney.
  • Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney.
  • Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney; Westmead Hospital, Sydney, Australia.
  • Smith JL; Westmead Hospital, Sydney, Australia.
  • Mollee P; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.
  • Burgess M; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.
  • Mapp S; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.
  • Keane C; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.
  • Atkinson V; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.
  • Parikh SA; Mayo Clinic, Rochester, USA.
  • Markovic SN; Mayo Clinic, Rochester, USA.
  • Ding W; Mayo Clinic, Rochester, USA.
  • Call TG; Mayo Clinic, Rochester, USA.
  • Hampel PJ; Mayo Clinic, Rochester, USA.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney.
  • Wargo JA; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwargo@mdanderson.org.
  • Ferrajoli A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.
Ann Oncol ; 34(9): 796-805, 2023 09.
Article em En | MEDLINE | ID: mdl-37414216
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_leukemia / 6_malignant_skin_melanoma Assunto principal: Leucemia Linfocítica Crônica de Células B / Melanoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Oceania Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_leukemia / 6_malignant_skin_melanoma Assunto principal: Leucemia Linfocítica Crônica de Células B / Melanoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Oceania Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos